What are the typical presentations of IgA (Immunoglobulin A) vasculitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 17, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

IgA Vasculitis: Clinical Presentation

IgA vasculitis presents with a classic tetrad of palpable purpura (predominantly on lower extremities), arthralgia/arthritis, abdominal pain, and glomerulonephritis with mesangial IgA deposits. 1, 2

Primary Clinical Features

Cutaneous Manifestations

  • Palpable purpura is the hallmark finding, appearing as round or oval lesions predominantly on the lower legs and buttocks 1
  • The purpura may also present in retiform patterns 1
  • Skin lesions result from perivascular IgA deposition and neutrophilic inflammation around cutaneous vessels 1

Musculoskeletal Involvement

  • Arthralgia or frank arthritis commonly occurs, typically affecting large joints 1, 2
  • Joint symptoms are usually self-limited 1

Gastrointestinal Manifestations

  • Abdominal pain is a dominant feature, ranging from mild discomfort to severe, intractable pain 1, 2
  • Gastrointestinal bleeding may occur 1
  • The severity of gastrointestinal manifestations determines short-term outcome 1, 3

Renal Involvement

  • Glomerulonephritis with mesangial IgA deposits (IgA vasculitis nephritis) develops in a significant proportion of patients 1, 2
  • Hematuria is a key presenting feature 2
  • Renal involvement is the primary determinant of long-term prognosis 1, 3

Less Common Manifestations

While rare, the following organ systems may be affected:

  • Pulmonary involvement 1, 3
  • Cardiac manifestations 1, 3
  • Genital symptoms 1, 3
  • Neurological complications 1, 3

Age-Related Differences in Presentation

Pediatric vs. Adult Disease

  • Children are affected 150-200 times more frequently than adults (incidence 1 in 1 million/year in adults) 1, 3
  • Adult-onset disease follows a more severe course with higher risk of chronic renal disease and end-stage renal failure 1, 4, 5
  • Up to one-third of adult patients may progress to end-stage renal failure with prolonged follow-up 3
  • Renal involvement is more frequent and severe in adults compared to children 4, 3

Pathophysiology Underlying Clinical Presentation

  • Immune complexes containing galactose-deficient IgA1 play a pivotal role 1
  • These complexes activate neutrophils via the Fc alpha receptor (CD89), causing perivascular inflammation in skin and mesangial proliferation in kidneys 1
  • The systemic nature of IgA deposition explains the multi-organ involvement pattern 1

Clinical Variants

IgA vasculitis can present in three distinct forms:

  • Systemic IgA vasculitis (classic Henoch-Schönlein purpura) with multi-organ involvement 1
  • Skin-limited IgA vasculitis restricted to cutaneous manifestations 1
  • IgA nephropathy as a kidney-restricted variant 1, 3

Key Diagnostic Pitfall

Do not confuse IgA vasculitis with ANCA-associated vasculitis – IgA vasculitis shows immune deposits (IgA) on biopsy, while ANCA-associated vasculitides typically lack immune deposits 6. This distinction is critical for appropriate management and prognosis.

References

Research

IgA vasculitis.

Seminars in immunopathology, 2021

Research

[Adult IgA vasculitis (Henoch-Schönlein purpura)].

Nephrologie & therapeutique, 2019

Research

Adult-onset IgA vasculitis (Henoch-Schönlein): Update on therapy.

Presse medicale (Paris, France : 1983), 2020

Research

IgA Vasculitis in Adults: a Rare yet Challenging Disease.

Current rheumatology reports, 2021

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.